HUTCHMED (China) (HMDCF) Change in Accured Expenses (2015 - 2025)

HUTCHMED (China) (HMDCF) reported Change in Accured Expenses of $221.1 million for Q2 2025, up 593.44% year-over-year from $31.9 million in Q2 2024, and down 99.33% quarter-over-quarter from $32.9 billion in Q4 2024.

HUTCHMED (China) (HMDCF) Change in Accured Expenses (2015 - 2025) Analysis & Trends

HUTCHMED (China) (HMDCF) has 11 years of Change in Accured Expenses data on file, last reported at $221.1 million in Q2 2025.

  • Change in Accured Expenses for Q2 2025 came in at $221.1 million, up 593.44% year-over-year; the trailing twelve-month figure through Jun 2025 was $221.1 million (up 593.44% YoY), and the FY2024 annual result was $2.4 million, up 155.18% from the prior year.
  • Change in Accured Expenses retreated to $221.1 million in Q2 2025 per HMDCF's latest filing, from $32.9 billion in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $34.7 billion in Q4 2023 and troughed at $9.9 million in Q1 2021.
  • A 5-year average of $6.8 billion and a median of $107.7 million in 2021 frame the typical range for Change in Accured Expenses.
  • On a YoY basis, Change in Accured Expenses climbed as much as 102575.61% in 2023 and fell as far as 87.59% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $27.1 million in 2021, then increased by 24.98% to $33.8 million in 2022, then surged by 102575.61% to $34.7 billion in 2023, then slipped by 5.15% to $32.9 billion in 2024, then slumped by 99.33% to $221.1 million in 2025.
  • Business Quant data shows HMDCF's Change in Accured Expenses at $221.1 million in Q2 2025, $32.9 billion in Q4 2024, and $31.9 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -144.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -234.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -12.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -14.30 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.89 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 10.02 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 23.00 Mn
10 HUTCHMED (China) - - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 221.06 Mn
Jun 30, 2025 221.06 Mn
Dec 31, 2024 32.95 Bn
Dec 31, 2024 32.95 Bn
Jun 30, 2024 31.88 Mn
Jun 30, 2024 31.88 Mn
Dec 31, 2023 34.73 Bn
Dec 31, 2023 34.73 Bn
Jun 30, 2023 28.98 Mn
Jun 30, 2023 28.98 Mn
Dec 31, 2022 33.83 Mn
Dec 31, 2022 33.83 Mn
Jun 30, 2022 233.61 Mn
Jun 30, 2022 233.61 Mn
Dec 31, 2021 27.07 Mn
Dec 31, 2021 27.07 Mn
Jun 30, 2021 181.61 Mn
Jun 30, 2021 181.61 Mn
Mar 31, 2021 9.94 Mn
Mar 31, 2021 9.94 Mn